In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Associate Professor Marek Gierlotka
Speaker
Associate Professor Marek Gierlotka
Marek Gierlotka Marek Gierlotka

University of Opole, Opole (Poland)

Specialities : Interventional Cardiology , Acute Cardiac Care, Acute Coronary Syndromes

The majority of my professional work is associated with the intensive cardiac care and invasive cardiology. In the spectrum of my professional interests lies optimization of myocardial infarction care and the most severe patients with acute and chronic heart failure. Now I work as a Head of Cardiology Department at the University Hospital in Opole where I moved from Silesian Centre for Heart Diseases in Zabrze. My scientific work focus on epidemiology and long-term prognosis of acute cardiovascular diseases along with the analysis of the impact of the diagnostic and therapeutic process on epidemiological indicators. I am an expert in the field of design, implementation and analysis of clinical registers and large databases (PL-ACS, AMI-PL, SILSTROKE registries). I am currently Co-chair of the Research and Science section of Acute Cardiovascular Care Association of ESC and Board Member of Polish Cardiac Society.

26 presentations from this speaker

Levosimendan use in AMI-related and non-AMI-related acute heart failure

Event : HFA Discoveries 2020

  • Session : HFA Discoveries - ePosters
  • Speaker : M Gierlotka (Opole,PL)

Predictors of early death in high risk acute heart failure patients treated with levosimendan

Event : ACVC Essentials 4 You 2020

  • Session : ACVC Essentials 4 You - ePublications
  • Speaker : M Gierlotka (Opole,PL)

Age and gender related performance of STEMI networks - how do we follow the ESC guidelines on ECG to PCI delay

Event : Acute Cardiovascular Care 2019

  • Session : Acute Coronary Syndromes - Pathophysiology and Mechanisms, Biomarkers , Treatment, Revascularization Poster Discussant
  • Speaker : M Gierlotka (Opole,PL)

ECG to PCI time delays - ESC recommendations and STEMI networks performance

Event : Acute Cardiovascular Care 2019

  • Session : ACCA Research Prize
  • Speaker : M Gierlotka (Opole,PL)

Introduction to the session.

Event : Acute Cardiovascular Care 2019

  • Session : Optimal management of patients with complex arrhythmias
  • Speaker : M Gierlotka (Opole,PL)

MINOCA matters! - Take home message

Event : Acute Cardiovascular Care 2019

  • Session : MINOCA matters!
  • Speaker : M Gierlotka (Opole,PL)

12-month mortality after early and late resuscitated cardiac arrest in acute myocardial infarction

Event : Acute Cardiovascular Care 2018

  • Session : ACCA Research Prize
  • Speaker : M Gierlotka (Opole,PL)

Complete revascularization in AMI patients with cardiogenic shock and multivessel disease

Event : Acute Cardiovascular Care 2018

  • Session : Moderated Poster Session 3 - Acute Coronary Syndromes II
  • Speaker : M Gierlotka (Opole,PL)

30-days outcome in NSTEMI patients treated with PCI is worse in those receiving GP IIb/IIIa blockers.

Event : ESC Congress 2013

  • Session : Antithrombotics and intervention in acute coronary syndromes
  • Speaker : M Gierlotka (Opole,PL)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are